athenahealth (ATHN) Coverage Initiated at Bank of America
Bank of America initiated coverage on shares of athenahealth (NASDAQ:ATHN) in a report released on Tuesday morning, MarketBeat reports. The firm issued a neutral rating and a $147.00 price objective on the health services provider’s stock.
A number of other research analysts have also recently commented on ATHN. BidaskClub upgraded shares of athenahealth from a strong sell rating to a sell rating in a report on Saturday, December 2nd. Deutsche Bank started coverage on shares of athenahealth in a report on Friday, December 8th. They issued a hold rating and a $145.00 price target on the stock. Citigroup started coverage on shares of athenahealth in a report on Thursday, January 4th. They issued a neutral rating on the stock. KeyCorp restated a buy rating and issued a $152.00 price target on shares of athenahealth in a report on Friday, January 12th. Finally, Evercore ISI started coverage on shares of athenahealth in a report on Thursday, January 18th. They issued an in-line rating and a $140.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, seventeen have issued a hold rating and seven have issued a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of $144.35.
athenahealth (NASDAQ ATHN) opened at $139.06 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84. athenahealth has a 1 year low of $95.01 and a 1 year high of $158.66. The firm has a market cap of $5,513.05, a price-to-earnings ratio of 81.36, a price-to-earnings-growth ratio of 2.36 and a beta of 1.17.
In other athenahealth news, Director Amy Abernethy sold 500 shares of the stock in a transaction dated Tuesday, December 26th. The shares were sold at an average price of $134.18, for a total transaction of $67,090.00. Following the transaction, the director now directly owns 4,045 shares in the company, valued at approximately $542,758.10. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jonathan Bush sold 5,000 shares of the stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $122.69, for a total transaction of $613,450.00. Following the sale, the chief executive officer now directly owns 320,807 shares of the company’s stock, valued at $39,359,810.83. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 102,003 shares of company stock worth $13,968,027. 3.20% of the stock is owned by company insiders.
Hedge funds have recently added to or reduced their stakes in the business. American International Group Inc. purchased a new stake in shares of athenahealth during the fourth quarter valued at about $124,000. Meadow Creek Investment Management LLC purchased a new stake in shares of athenahealth during the fourth quarter valued at about $132,000. The Manufacturers Life Insurance Company lifted its position in shares of athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after buying an additional 84 shares during the last quarter. Ameriprise Financial Inc. purchased a new stake in shares of athenahealth during the second quarter valued at about $206,000. Finally, Columbia Partners L L C Investment Management purchased a new stake in shares of athenahealth during the fourth quarter valued at about $204,000.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.